|
EP0489116B1
(en)
|
1989-08-22 |
1994-04-06 |
Immunex Corporation |
Fusion proteins comprising gm-csf and il-3
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US5914254A
(en)
|
1993-08-02 |
1999-06-22 |
Celtrix Pharmaceuticals, Inc. |
Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
|
|
US7101974B2
(en)
|
2000-03-02 |
2006-09-05 |
Xencor |
TNF-αvariants
|
|
DE60334303D1
(de)
|
2002-07-03 |
2010-11-04 |
Tasuku Honjo |
Immunpotenzierende zusammensetzungen
|
|
US20110020273A1
(en)
|
2005-04-06 |
2011-01-27 |
Ibc Pharmaceuticals, Inc. |
Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
|
|
EP1812038A1
(en)
|
2004-11-18 |
2007-08-01 |
VIB vzw |
Fibronectin iii domain as leptin receptor antagonists
|
|
WO2006115800A2
(en)
|
2005-04-15 |
2006-11-02 |
The Regents Of The University Of California |
Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha
|
|
US7947265B2
(en)
|
2006-08-02 |
2011-05-24 |
Mcgill University |
Fusion proteins and methods for modulation of immune response
|
|
WO2008124086A2
(en)
|
2007-04-05 |
2008-10-16 |
President And Fellows Of Harvard College |
Chimeric activators: quantitatively designed protein therapeutics and uses thereof
|
|
WO2009003145A1
(en)
|
2007-06-26 |
2008-12-31 |
University Of Miami |
Antibody-endostatin fusion protein and its variants
|
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
ES2536772T3
(es)
|
2007-09-21 |
2015-05-28 |
The Regents Of The University Of California |
El interferón dirigido demuestra potentes actividades apoptóticas y antitumorales
|
|
WO2010030671A1
(en)
|
2008-09-09 |
2010-03-18 |
University Of Medicine And Dentistry Of New Jersey |
Type i interferon antagonists
|
|
US8334101B2
(en)
|
2008-09-26 |
2012-12-18 |
University Of Massachusetts |
Intracellular DNA receptor
|
|
CA2749558C
(en)
|
2008-12-08 |
2019-01-15 |
Complix Nv |
Single-chain antiparallel coiled coil proteins
|
|
JP2012521199A
(ja)
|
2009-03-23 |
2012-09-13 |
ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ |
免疫応答を調節するための化合物および方法
|
|
RU2583876C2
(ru)
|
2009-08-17 |
2016-05-10 |
Роше Гликарт Аг |
Иммуноконъюгаты направленного действия
|
|
CN102497885A
(zh)
|
2009-09-10 |
2012-06-13 |
赛托斯生物技术公司 |
白介素-1β突变蛋白偶联物在糖尿病治疗中的用途
|
|
RU2577299C2
(ru)
|
2011-07-04 |
2016-03-10 |
Олег Ильич Эпштейн |
Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
|
|
WO2012170072A1
(en)
|
2011-06-06 |
2012-12-13 |
Immungene, Inc. |
Engineered antibody-tnfsf member ligand fusion molecules
|
|
WO2013053008A2
(en)
|
2011-10-14 |
2013-04-18 |
The Walter And Eliza Hall Institute Of Medical Research |
Molecules which bind clec9a
|
|
CN104203982B
(zh)
|
2011-10-28 |
2018-08-31 |
特瓦制药澳大利亚私人有限公司 |
多肽构建体及其用途
|
|
WO2013107791A1
(en)
|
2012-01-20 |
2013-07-25 |
Vib Vzw |
Targeted mutant alpha-helical bundle cytokines
|
|
PL2822575T3
(pl)
|
2012-03-03 |
2020-08-10 |
Immungene, Inc. |
Zmodyfikowane sposobami inżynierii cząsteczki fuzyjne przeciwciało-mutant interferonu
|
|
US20150132302A1
(en)
|
2012-05-01 |
2015-05-14 |
The University Of Sydney |
Vaccine and uses thereof
|
|
WO2014023709A1
(en)
|
2012-08-09 |
2014-02-13 |
Roche Glycart Ag |
Asgpr antibodies and uses thereof
|
|
KR20150131208A
(ko)
|
2013-03-13 |
2015-11-24 |
이미지냅 인코포레이티드 |
Cd8에의 항원 결합 구조체들
|
|
CN114732017A
(zh)
|
2013-04-29 |
2022-07-12 |
阿格罗塞文公司 |
包含结合至鞘脂的抗体的农用化学组合物
|
|
KR102322510B1
(ko)
|
2013-07-18 |
2021-11-08 |
브이아이비 브이지더블유 |
수용체 결합친화성이 현격히 감소된 사이토카인을 수반하는 푸소카인
|
|
US9732135B2
(en)
|
2013-07-19 |
2017-08-15 |
Vib Vzw |
Targeting of human interferon antagonists
|
|
CA2918518C
(en)
|
2013-07-19 |
2022-08-16 |
Universiteit Gent |
Targeted modified il-1 family members
|
|
MX370565B
(es)
|
2013-07-19 |
2019-12-17 |
Vib Vzw |
Miembros de la familia tnf modificados dirigidos.
|
|
SI3030575T1
(sl)
|
2013-08-08 |
2018-11-30 |
Cytune Pharma |
Modulokini na osnovi IL-15 in IL-15R-alfa sushi domene
|
|
UA119352C2
(uk)
|
2014-05-01 |
2019-06-10 |
Тева Фармасьютикалз Острейліа Пті Лтд |
Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
|
|
WO2016187459A1
(en)
|
2015-05-20 |
2016-11-24 |
The Regents Of The University Of California |
Method for generating human dendritic cells for immunotherapy
|
|
EP3371311B1
(en)
|
2015-11-06 |
2021-07-21 |
Orionis Biosciences BV |
Bi-functional chimeric proteins and uses thereof
|
|
CN109071632B
(zh)
*
|
2016-02-05 |
2022-12-30 |
奥里尼斯生物科学私人有限公司 |
靶向性治疗剂及其用途
|
|
US11248057B2
(en)
|
2016-03-07 |
2022-02-15 |
Vib Vzw |
CD20 binding single domain antibodies
|
|
US11291721B2
(en)
*
|
2016-03-21 |
2022-04-05 |
Marengo Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
EP3455245A2
(en)
|
2016-05-13 |
2019-03-20 |
Orionis Biosciences NV |
Therapeutic targeting of non-cellular structures
|
|
WO2017194783A1
(en)
|
2016-05-13 |
2017-11-16 |
Orionis Biosciences Nv |
Targeted mutant interferon-beta and uses thereof
|
|
CN110114368B
(zh)
|
2016-10-24 |
2024-08-02 |
奥睿尼斯生物科学私人有限公司 |
靶向突变干扰素-γ及其用途
|
|
KR102642385B1
(ko)
|
2017-02-06 |
2024-03-04 |
오리오니스 바이오사이언시스 엔브이 |
표적화된 키메라 단백질 및 이의 용도
|
|
EP3576765B1
(en)
*
|
2017-02-06 |
2025-07-16 |
Orionis Biosciences, Inc. |
Targeted engineered interferon and uses thereof
|
|
CA3050601A1
(en)
|
2017-02-07 |
2018-08-16 |
Vib Vzm |
Immune-cell targeted bispecific chimeric proteins and uses thereof
|
|
CN117924493A
(zh)
|
2017-08-09 |
2024-04-26 |
奥里尼斯生物科学有限公司 |
Clec9a结合剂及其用途
|
|
EP3664829A4
(en)
|
2017-08-09 |
2021-05-05 |
Orionis Biosciences, Inc. |
LIAISON OFFICERS AT PD-1 AND PD-L1
|
|
EP3665201A4
(en)
|
2017-08-09 |
2021-06-02 |
Orionis Biosciences, Inc. |
CD8 BINDERS
|
|
US12655186B2
(en)
|
2018-01-26 |
2026-06-16 |
Orionis Biosciences, Inc. |
Chimeric protein comprising anti-XCR1 antibody and modified interferon alpha 2
|
|
CA3090406A1
(en)
|
2018-02-05 |
2019-08-08 |
Orionis Biosciences, Inc. |
Fibroblast binding agents and use thereof
|
|
KR20260100427A
(ko)
*
|
2018-03-28 |
2026-06-29 |
오리오니스 바이오사이언시즈 인코포레이티드 |
이작용성 단백질 및 이의 작제물
|
|
EP3833391A4
(en)
|
2018-08-08 |
2022-08-10 |
Orionis Biosciences, Inc. |
ANTI-SIRP1ALPHA CHIMERIC PROTEINS AND USES THEREOF
|
|
CN113840833B
(zh)
*
|
2019-03-28 |
2025-06-17 |
奥里尼斯生物科学股份有限公司 |
基于clec9a的嵌合蛋白复合物
|